Feasibility of Integrating Panel-Based Pharmacogenomics Testing for Chemotherapy and Supportive Care in Patients With Colorectal Cancer

INTRODUCTION: Pharmacogenomics is about selecting the “right drug in the right amount for the right patient.” In metastatic colorectal cancer, germline pharmacogenomics testing presents a unique opportunity to improve outcomes, since the genes dihydropyrimidine dehydrogenase and UDP-glucuronosyltran...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Technol Cancer Res Treat
Main Authors: Kasi, Pashtoon Murtaza, Koep, Tyler, Schnettler, Erica, Shahjehan, Faisal, Kamatham, Vaishnavi, Baldeo, Candice, Hughes, Caren L.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6753511/
https://ncbi.nlm.nih.gov/pubmed/31533552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1533033819873924
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados